1. Fascin and esophageal squamous cell carcinoma
   Yinwei Cheng et al, 2017, Precision Radiation Oncology CrossRef
2. The interplay of extracellular matrix and microbiome in urothelial bladder cancer
   Massimo Alfano et al, 2016, Nature Reviews Urology CrossRef
3. Fascin-1: Updated biological functions and therapeutic implications in cancer biology
   Chien-Hsiu Li et al, 2022, BBA Advances CrossRef
4. Soluble CD138/Syndecan-1 Increases in the Sera of Patients with Moderately Differentiated Bladder Cancer
   Mohammad Nabi Sanaee et al, 2015, Urologia Internationalis CrossRef
5. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer
   Zhi Wang et al, 2021, BMC Cancer CrossRef
6. CD147 as a novel biomarker for predicting the prognosis and clinicopathological features of bladder cancer: a meta-analysis
   Hongru Li et al, 2017, Oncotarget CrossRef
7. Fascin-1 and Its Role As a Serological Marker in Prostate Cancer: a Prospective case–control Study
   Octavian Sabin Tătaru et al, 2021, Future Science OA CrossRef
8. Expression of c-erb-B2 gene in bladder cancer of Egyptian patients and its correlation with p53 and bcl-2
   Saber A. Sakr et al, 2015, Biomedicine & Pharmacotherapy CrossRef
9. CD147-induced cell proliferation is associated with Smad4 signal inhibition
   Hui Qin et al, 2017, Experimental Cell Research CrossRef
10. Regulatory mechanisms of miR-145 expression and the importance of its function in cancer metastasis
    Tahereh Zeinali et al, 2019, Biomedicine & Pharmacotherapy CrossRef
11. Fascin actin-bundling protein 1 in human cancer: Promising biomarker or therapeutic target?
    Hongliang Liu et al, 2021, Molecular Therapy - Oncolytics CrossRef
12. The Role of Fascin-1 in Human Urologic Cancers: A Promising Biomarker or Therapeutic Target?
    Naibin Zhang et al, 2023, Technology in Cancer Research & Treatment CrossRef